Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-3-31
pubmed:abstractText
Recent trials have shown that high-dose HMG-CoA reductase inhibitor (statin) therapy reduces cardiovascular events in high-risk subjects within weeks of initiating therapy. We investigated the effect of time to titration to maximum dose of statin therapy on cardiovascular events.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1175-3277
pubmed:author
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
103-7
pubmed:dateRevised
2009-7-28
pubmed:meshHeading
pubmed-meshheading:19331438-Cardiovascular Diseases, pubmed-meshheading:19331438-Cholesterol, LDL, pubmed-meshheading:19331438-Databases, Factual, pubmed-meshheading:19331438-Dose-Response Relationship, Drug, pubmed-meshheading:19331438-Female, pubmed-meshheading:19331438-Guideline Adherence, pubmed-meshheading:19331438-Hospitals, Veterans, pubmed-meshheading:19331438-Humans, pubmed-meshheading:19331438-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:19331438-Male, pubmed-meshheading:19331438-Medical Records Systems, Computerized, pubmed-meshheading:19331438-Middle Aged, pubmed-meshheading:19331438-Practice Guidelines as Topic, pubmed-meshheading:19331438-Retrospective Studies, pubmed-meshheading:19331438-Risk Assessment, pubmed-meshheading:19331438-Simvastatin, pubmed-meshheading:19331438-Time Factors, pubmed-meshheading:19331438-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
Effect of time to titration to maximum dose of statins on cardiovascular outcomes: a retrospective analysis in high-risk patients.
pubmed:affiliation
Richard L. Roudebush VA Medical Center, Indianapolis, Indiana 46202, USA.
pubmed:publicationType
Journal Article